Search Results - De Castro J
- Showing 1 - 1 results of 1
-
1
Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer by Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book